Grace Ranch Tucson, Iowa State Penitentiary Famous Inmates, Bridgeport, Chicago Crime, Why Does Holden Write The Composition For Stradlater, Forest Service Handbook Uniform Policy, Articles G

Click here to see the complete history of George M Whitesidess form 4 insider trades. The estimated Net Worth of George M Whitesides is at least $382 Mille dollars as of 11 August 2017. Its research is focused in the areas of inflammation and immunology. no insider transaction in Theravance Biopharma Inc (TBPH). CEO of La Jolla Pharmaceutical Larry G. Edwards 0 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years. estimated net worth of George M Whitesides, Select a Column Field to add to the results, Refer a Friend and Earn One Month of Free Membership. a net Trade. You can see the complete history of George Whitesides stock trades at the bottom of the page. Details can be seen in George M Whitesides's Latest Holdings Summary section. The estimated Net Worth of George Thomas Whitesides is at least $1.43 Million dollars as of 11 May 2020. Whitesides have co-founded twelve companies with a combined market capitalization. (2022) Charge Transport Measured Using the EGaIn Junction through Self-Assembled Monolayers Immersed in Organic Liquids.The Journal of Physical Chemistry. [8] Whitesides and his research group have made significant contributions by developing techniques for soft lithography and microcontact printing. Full Summary. The estimated Net Worth of George M Whitesides is at least $372 Thousand dollars as of 11 August 2017. AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table. In addition, he makes $337,879 as Independent Director at Theravance Biopharma Inc. . For innovative and far-ranging research in chemistry, biology, biochemistry and material science, pioneering work of technological interest and his extensive involvement with teaching, government and industry. You can help our author matching system! He now . purchase sale George McClelland Whitesides (born August 3, 1939) is an American chemist and professor of chemistry at Harvard University. , and Slow Crack Growth in Single-Crystal Silicon. A native of Kentucky, Whitesides earned a bachelors degree from Harvard in 1960 and 1964 with his advisor John D. Roberts (a fellow NMS recipient), a doctorate in chemistry from the California Institute of Technology. Advisory Positions (1980 - present)National Research Council: Board on Chemical Sciences and Technology (1984-89; Chairman, 1986-99); Naval Studies Board (1989-97; Vice Chairman, 1992-97); Committee on Bioprocess Engineering (1991-92); Board on Science, Technology and Economic Policy (1991-97); Visiting Committee to NIST/ATP on Advanced Technology (1994-97); Board on Physics and Astronomy (1997-2001) Committee on Science and Technology for Counter Terrorism (2002); Committee on Nanotechnology for the Intelligence Community (2003); Committee on Prospering in a Global Economy (the "Gathering Storm" Committee, 2005); Committee on Science, Engineering and Public Policy (COSEPUP, 2005-2013, Chairman); Committee on Forefronts of Science at the Interface of Physical and Life Sciences (2007-08); Committee on Determining Core Capabilities in Chemical and Biological Defense Research and Development (Advisor, 2012);National Science Foundation: Chemistry Advisory Committee (1984-86; Chairman, 1986), Materials Research Advisory Committee (1991-93; Chairman, 1993), Review Panel for the Materials Research Laboratories (1993, co-Chairman); Advisory Committee for Mathematics and Physical Sciences (1993-96); NSF Senior Assessment Panel: International Assessment of U. S. Mathematical Sciences (1997); Workshop on Chemical Bonding Centers, (2003); Workshop on Chemistry and Cognition (2004); NBIC/Convergence Committee (Chairman, 2012)Department of Defense: Defense Advanced Research Projects Agency Defense Science Research Council (1984-2013); Defense Science Board (1993-2003); Threat Reduction Advisory Committee to the Defense Threat Reduction Agency (1998- 2006); Defense Science Board Task Force on Deterring Weapons of Mass Destruction (2015-)National Aeronautics and Space Administration (NASA): Biological and Physical Research Maximization and Prioritization (REMAP) Task Force (2002).Other: M.I.T. of 7,828 shares made by C Ann Merrifield 7. George M Whitesides is the director of AMAG Pharmaceuticals Inc. He is also a fellow of the American Association for the Advancement of Science and the American Philosophical Society. , George Whitesides owns over 1,300 units of Virgin Galactic Inc stock worth over $1,425,412 and over the last 3 years George sold SPCE stock worth over $0. Whitesides currently holds one of the 21 university professorships at Harvard. Birth, Age, Ethnicity, Nationality. Bei Erweiterung erscheint eine Liste mit Suchoptionen, die die Sucheingaben so ndern, dass sie zur aktuellen Auswahl passen. Dan David Prize in the Future Time Dimension, No Small Matter: Science on the Nanoscale, Enzymes in Synthetic: Organic Chemistry George M. Whitesides. The most active insiders traders include Plc Gsk, Inc. Innoviva, e Deepika Pakianathan. George M Whitesides Net Worth 2022 and insider trades. Whitesides Current research interests include physical and organic chemistry, complexity and simplicity, materials science, biophysics, technology for developing economies, biology tools, and lifes origin. "[11] He has shifted to new research areas many times throughout his career, averaging about ten years in any particular area. George M Whitesides a scientist was born August 3, 1939, in the beautiful city of Louisville, KY. He also studied spin-spin coupling in a variety of organic compounds, using density matrix calculations to examine the spin systems that NMR analyses detect. George M Whitesides is Theravance Biopharma Inc (TBPH) Though Whitesides had never heard of that school and recalled that he was unknown where New England was, he agreed to go. March 3, 2023 by cyfrows. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. sale The estimated net worth of George M Whitesides is at least $2 Million dollars as of 2023-03-04. Last Updated on June 9, 2019. Over the past 18 months, sale During the past 18 months, 140,513 shares of Theravance Biopharma Inc (TBPH) were sold and 0 shares were bought by its insiders, resulting in a net Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. . [8], Whitesides has made scientific contributions in diverse areas, including nuclear magnetic resonance spectroscopy (NMR), microfluidics and nanotechnology. sale [4][5][6], Whitesides attended secondary school at Phillips Andover and graduated in 1957. sale You can select different timeframes to see how George M Whitesides's insider trading performs compared to the benchmark. [8] He used NMR spectroscopy to study rate of change of Grignard reagents[9] and the structure of Grignard reagents in solution. [25], Beyond his scientific research, Whitesides is also active in public service. director & Executive Chair Harlan Waksal We share information about different celebrities, Biography of scientists, inventor etc. From 1982 to 1991 he was a member of the Department of Chemistry at Harvard University and Chairman of the Department of Chemistry from 1986 to 1989. and From 1982 to 2004, Whitesides worked as a Mallinckrodt Professor of Chemistry. [24], Whitesides is also known for publishing his "outline system" for writing scientific papers. Niagara Falls, NY. George Thomas Whitesides is an American businessman. Check out Eli Whiteside's net worth in US Dollar Feb, 2023. Other key executives at Innoviva Inc include Chief Accounting Officer Marianne Zhen Erica Paladino. Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. FAQ: What is George Whitesides networth in 2020? Only the transactions in Open Market or Private Sale at the market prices are included. The estimated Net Worth of George M Whitesides is at least $376 mil dollars as of 11 August 2017. CEO of La Jolla Pharmaceutical Larry G. Edwards . Flowers University Professor. George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $34,480 and over the last 8 years he sold TBPH stock worth over $0. , In 1982, Whitesides returned to the Department of Chemistry at Harvard University with his alma mater and took the laboratory with him. Get TED Talks picked just for you. Roberts) in 1964. sale , It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Flowers University Research Professor. The estimated Net Worth of George M Whitesides is at least $380 Tisc dollars as of 11 August 2017. Most recently he bought 4,000 units of TBPH stock worth $98,760 on 11 August 2017. Fundamental company data provided by Morningstar, updated daily. The most recent stock trade was executed by Rick E Winningham on 14 December 2022, trading 50,000 units of TBPH stock currently worth $559,500. The estimated Net Worth of George M Whitesides is at least $372 Tausend dollars as of 11 August 2017. 10 percent owner Camber Capital Management Llc This article about a chief executive from the United States is a stub. Enjoy a 7-Day Free Trial Thru Mar 11, 2023! History at Harvard University is noted for its diversity, creativity, and productivity, and for the quality of the students, it produces. [26] Two key challenges were identified as being essential to American scientific and engineering prowess: 1) creating high-quality jobs for Americans and 2) addressing the nation's need for clean, affordable, and reliable energy. As the Independent Director of Theravance Biopharma Inc, the total compensation of George Whitesides at Theravance Biopharma Inc is $337,879. 10 percent owner Eli Samaha and , Dieser Button zeigt den derzeit ausgewhlten Suchtyp an. He . 2 Family, Parents, Siblings, Education. Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. sale He joined the Department of Chemistry of Harvard University in 1982, and was Department Chairman 1986-89, and Mallinckrodt Professor of Chemistry from 1982-2004. George Washington University. FAQ: How old is George Whitesides? He has served as a coach for Zero Gravity Corporation's parabolic flight service. On average, Theravance Biopharma Inc executives and independent directors trade stock every 67 days with the average trade being worth of $170,082. George Clooney is one of . In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Highlights of Research and Education Contributions (12/5/18): Graduate students: 168 graduated, 2 current; Post docs: 293 total, 18 current, Trainees in academic positions: 64 (last 10 yrs); Startup companies founded: 10 (last 10 yrs); New jobs created: ~1,000, Web of Science (WoS): h-index: 213; Total citations 196,416, Copyright 2023 The President and Fellows of Harvard College, Adaptive Materials, Composites and Polymers, Density as a Tool for Chemistry and Biology, Diagnostics, Bioanalytics and other Tools for Global Health, Microfluidics in Polymers, Paper, and Thread, Soft Lithography and Unconventional Nanofabrication. You might contact George M Whitesides via mailing address: C/o Advanced Magnetics Inc, 61 Mooney Street, Cambridge Ma 02138. , George Whitesides owns over 4,000 units of Theravance Biopharma Inc stock worth over $37,800 and over the last 8 years he sold TBPH stock worth over $0. 2020-21 Jimmy Murphy Young Player of the Year. [28] They identified chemical biology and materials science as important areas for new development in the United Kingdom, and argued that chemistry is an important discipline in part because its concepts, processes and materials underlie other disciplines and offer opportunities to enhance communication between disciplines. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. of 22,076 shares made by Richard A Graham Above is the net worth, insider trading, and ownership report for George M Whitesides. Visiting Scholar. 1964 (Caltech . [38][39] Whitesides has mentored more than 300 graduate students, postdocs, and visiting scholars. , Hail State plays at Vanderbilt on Saturday. To know more about George M Whitesides visit Hollywoodsbio.com. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Science. On average, George trades about 364 units every 0 days since 2014. 193983. Theravance Biopharma, Inc. is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. [57][58] In 2013 he was awarded the IRI Medal alongside Robert S. cost His first appointment was in the chemistry department at MIT. Non-U.S: International Committee to Assess the Status of Chemistry in the UK (EPSRC, 2003; chairman); Advisory Board for Mesa+ (U. Twente, 2004-6); Advisory Committee for the ISAS (Dortmund, 2005-6 ); Genomics Research Center (Taiwan, 2006 - ; chairman); Academia Sinica (Taiwan, ISAB, 2008- chairman); Board of Governors of the Academy of Scientific and Innovative Research, AcSIR, (India, 2010-); International Technology Advisory Board, Office of Strategic R&D Planning, Ministry of Knowledge (Republic of Korea, 2010-2012); Professor, AcSIR, India (2011-); Euro-Chemistry Advisory Board (2011-), Wellcome Trust Affordable Healthcare Committee, UK (2011 - 2014).